We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BKG:LSEBerkeley Group Holdings plc Analysis

Data as of 2026-03-11 - not real-time

£3,892.00

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at £38.92, well below its 20‑day SMA of £42.09 and the 200‑day SMA of £39.02, indicating a near‑term price weakness but also a clear support cushion at £37.96. Technical momentum remains mixed: RSI sits at 32.9 (oversold), while the MACD histogram is deep in the red and signals a bearish crossover, suggesting caution on immediate upside. Despite the short‑term bearish signals, the broader trend is still classified as bullish, and the 30‑day volatility of 27.9% is moderate for a consumer‑cyclical stock. Fundamentally, the company trades at a forward PE of 11.25 and a trailing PE of 10.58, well below the sector average, while the DCF‑derived fair value of £69.26 points to roughly a 10‑11% upside from today’s price. The balance sheet is strong with a debt‑to‑equity of 18.9% and cash of £1.02 bn, and the dividend payout ratio is only 9%, supporting a sustainable 1.67% yield. Recent material news includes a share‑repurchase program that cancelled 40,000 shares and notable insider buying of £1.37 m, both of which reinforce confidence from management and insiders.
The low beta of 0.34 indicates limited sensitivity to broader market moves, and the Fear & Greed Index is sitting at “Extreme Greed,” reflecting strong investor appetite for risk assets. The residential construction sector is inherently cyclical, but the company’s high operating margin of 20.8% and solid free cash flow of £448 m provide a cushion against downturns. With a dividend yield of 1.67% and a payout ratio under 10%, the dividend appears sustainable even if earnings dip modestly. The current market cap of £3.67 bn and rising volume suggest adequate liquidity for most investors. Given the modest upside, strong fundamentals, and defensive balance sheet, the stock is judged to be undervalued and more of a value play than a growth story. Investors should consider buying on dips, holding through the medium term, and keeping the position for the long run as the company capitalises on UK housing demand.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Oversold RSI indicating near‑term bounce
  • Support level at £37.96 provides downside cushion
  • Recent share repurchase boosts earnings per share

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Bullish longer‑term trend with DCF upside
  • Strong cash generation and low leverage
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Secular demand for UK housing
  • Defensive balance sheet and low beta
  • Value orientation with attractive valuation multiples

Key Metrics & Analysis

Financial Health

Revenue Growth-7.80%
Profit Margin15.29%
P/E Ratio10.6
ROE10.27%
ROA4.53%
Debt/Equity18.94
P/B Ratio103.4
Op. Cash Flow£112.8M
Free Cash Flow£448.1M

Technical Analysis

TrendBullish
RSI32.9
Support£3,796.00
Resistance£4,442.00
MA 20£4,209.30
MA 50£4,118.52
MA 200£3,902.36
MACDBearish
VolumeIncreasing
Fear & Greed Index78.16

Valuation

Fair Value£6,926.23
Target Price£4,314.53
Upside/Downside10.86%
GradeUndervalued
TypeValue
Dividend Yield1.67%

Risk Assessment

Beta0.34
Volatility27.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.